PillInsulin Degludec
Brands: Tresiba · Insulin Degludec
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 9 | SUPPLYING |
| A-S Medication Solutions | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 21, 2025RESOLVEDShortage resolved: Insulin Degludec Injection (Novo Nordisk, Inc.)
Insulin Degludec Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Jul 21, 2025SHORTAGEDrug shortage: Insulin Degludec Injection (Novo Nordisk, Inc.)
Insulin Degludec Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
- Mar 22, 2021RECALLRecall (Class I): TRESIBA FlexTouch (insulin degludec injection) 200 units/mL (U-200), 3 mL Prefilled Pen, Sample, Rx only, Manufactured …
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA
- Mar 22, 2021RECALLRecall (Class I): TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx only, Manufactured…
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA
- Mar 22, 2021RECALLRecall (Class I): TRESIBA (insulin degludec injection) 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx only, …
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA